@article{537af76f20054a55a37f81be91770622,
title = "Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry",
abstract = "To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register.",
keywords = "anti-TNF therapy, rheumatoid arthritis, anti-TNF therapy, rheumatoid arthritis",
author = "Fabiola Atzeni and Piercarlo Sarzi-Puttini and Costantino Botsios and Antonio Carletto and Paola Cipriani and Favalli, {Ennio Giulio} and Elena Frati and Valentina Foschi and Stefania Gasparini and Annarita Giardina and Elisa Gremese and Florenzo Iannone and Marco Sebastiani and Tamara Ziglioli and Domenico Biasi and Clodoveo Ferri and Mauro Galeazzi and Roberto Gerli and Roberto Giacomelli and Roberto Gorla and Marcello Govoni and Giovanni Lapadula and Antonio Marchesoni and Fausto Salaffi and Leonardo Punzi and Giovanni Triolo and Gianfranco Ferraccioli",
year = "2012",
doi = "10.1016/j.autrev.2012.06.008",
language = "English",
volume = "12",
pages = "225--229",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",
}